Vitamin A has diverse biological functions and is essential for human survival at every point from embryogenesis to adulthood.
Vitamin A and its derivatives have been used to treat human diseases including vision diseases,
skin diseases, and
cancer. Both insufficient and excessive
vitamin A uptake are detrimental, but how its transport is regulated is poorly understood. STRA6 is a multitransmembrane domain
cell-surface receptor and mediates
vitamin A uptake from plasma
retinol binding protein (RBP). STRA6 can mediate both cellular
vitamin A influx and efflux, but what regulates these opposing activities is unknown. To answer this question, we purified and identified STRA6-associated
proteins in a native mammalian cell type that takes up
vitamin A through STRA6 using mass spectrometry. We found that the major
protein repeatedly identified as STRA6-associated
protein is
calmodulin, consistent with the cryogenic electron microscopy (cryo-EM) study of zebrafish STRA6 associated with
calmodulin. Using radioactivity-based, high-performance liquid chromatography (HPLC)-based and real-time fluorescence techniques, we found that
calmodulin profoundly affects STRA6's
vitamin A transport activity. Increased
calcium/
calmodulin promotes cellular
vitamin A efflux and suppresses
vitamin A influx through STRA6. Further mechanistic studies revealed that
calmodulin enhances the binding of apo-RBP to STRA6, and this enhancement is much more pronounced for apo-RBP than holo-RBP. This study revealed that
calmodulin regulates STRA6's
vitamin A influx or efflux activity by modulating its preferential interaction with apo-RBP or holo-RBP. This molecular mechanism of regulating
vitamin A transport may point to new directions to treat human diseases associated with insufficient or excessive
vitamin A uptake.